Molecular analysis of anti-apoptotic action in MALT lymphoma and its clinical application for diagnosis and treatment.
Molecular analysis of anti-apoptotic action in MALT lymphoma and its clinical application for diagnosis and treatment.
批准号:
17591023
负责人:
HOSOKAWA Yoshitaka
金额:
$2.24万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
点击翻译按钮获取中文摘要
英文摘要
API2-MALT1. t(11;18)(q21;q21) is a characteristic chromosomal translocation in mucosa-associated lymphoid tissue (MALT) type lymphoma, and this translocation results in chimeric transcript of API2 (Apoptosis Inhibitor 2, also known as c-IAP2)-MALT1 (Mucosa-Associated Lymphoma Translocation gene 1). To identify proteins that bind API2-MALT1 chimeric protein, we employed coimmunoprecipitation and SDS PAGE analysis, followed by liquid chromatography-electrospray ionization tandem mass spectrometry. As a result, Smac, Htra2, and TRAF2 were identified as API2-MALT1-binding proteins.Immunoprecipitation analysis demonstrated that ectopically expressed API2-MALT1 protein indeed binds to these endogeneous proteins. Furthermore, API2-MALT1 protein significantly inhibited Smac-promoted apoptosis in UV irradiated HeLa cells. These data strongly suggest that API2-MALT1 can block apoptosis, at least in part, by inhibiting Smac-mediated apoptotic pathway. Further study is warranted to investigate the detailed molecular mechanism of API2-MALT1 and its clinical application.
期刊论文(15)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Molecular pathogenesis of MALT lymphoma : two signaling pathways underlying the antiapoptotic of API2-MALT1 fusion protein
MALT淋巴瘤的分子发病机制:API2-MALT1融合蛋白抗凋亡的两条信号通路
DOI:
--
发表时间:
2006
期刊:
Leukemia 20
影响因子:
--
作者:
[Hamaguchi I, Morisada T, Azuma M, Murakami K, Kuramitsu M, Mizukami T, Ohbo K, Yamaguchi K, Oike Y, Dumont DJ, Suda T, Nakagawa M et al.]
通讯作者:
Nakagawa M et al.
Molecular pathogenesis of MALT lymphoma : two signaling pathways underlying anti-apoptotic effect of API2-MALT1 fusion protein
MALT淋巴瘤的分子发病机制:API2-MALT1融合蛋白抗凋亡作用的两条信号通路
DOI:
--
发表时间:
期刊:
Leukemia (In press)
影响因子:
--
作者:
[Tsujimura K, et al., Nakagawa et al.]
通讯作者:
Nakagawa et al.
Anti-apoptotic action of API2-MALT1 fusion protein involved in t(11;18)(q21;q21) MALT lymphoma.
API2-MALT1 融合蛋白参与 t(11;18)(q21;q21) MALT 淋巴瘤的抗凋亡作用。
DOI:
--
发表时间:
2005
期刊:
Apoptosis 10
影响因子:
--
作者:
[Hosokawa Y et al.]
通讯作者:
Hosokawa Y et al.
API2-MALT1 fusion protein induces transcriptional activation of the API2 gene through NF-кB binding elements; evidence for a positive feed-back loop pathway resulting in unremitting NF-кB activation.
API2-MALT1 融合蛋白通过 NF-кB 结合元件诱导 API2 基因的转录激活;证据表明正反馈环路途径导致 NF-кB 持续激活。
DOI:
--
发表时间:
2005
期刊:
Biochem.Biophys.Res.Commun. 334
影响因子:
--
作者:
[Hosokawa Y, Suzuki H, Nakagawa M, Lee TH, Seto M.]
通讯作者:
Seto M.
API2-MALT1 fusion protein induces transcriptional activation of the API2 gene through NF-κB binding elements; evidence for a positive feed-back loop pathway resulting in unremitting NF-κB activation.
API2-MALT1 融合蛋白通过 NF-κB 结合元件诱导 API2 基因的转录激活;证据表明正反馈环路途径导致 NF-κB 持续激活。
DOI:
--
发表时间:
2005
期刊:
Biochem. Biophys. Res. Commun 334
影响因子:
--
作者:
[Nagamatsu G, Ohmura M, Mizukami T, Hamaguchi I, Hirabayashi S, Yoshida S, Hata Y, Suda T, Ohbo K, Hosokawa Y et al.]
通讯作者:
Hosokawa Y et al.
共 8 条
Basic study of the bioactive substances of a skin of citrus fruits for periodontal disease treatment
-
批准号:19K10151
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2019
-
负责人:HOSOKAWA Yoshitaka
-
依托单位:
Analysis of leukocyte infiltration mechanism to participate in inflammatory bone resorption in periodontal lesion
-
批准号:16K11834
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.83万
-
财政年份:2016
-
负责人:HOSOKAWA Yoshitaka
-
依托单位:
Analysis of Th17 cells migration and activation in periodontally diseased tissues
-
批准号:25463219
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2013
-
负责人:HOSOKAWA Yoshitaka
-
依托单位:
Analysis of Th17 cells migration inperiodontally diseased tissues.
-
批准号:23792479
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.66万
-
财政年份:2011
-
负责人:HOSOKAWA Yoshitaka
-
依托单位:
Analysis of Th17 cells migration and activation in periodontally diseased tissues.
-
批准号:21792123
-
项目类别:Grant-in-Aid for Young Scientists (B)
-
资助金额:$2.75万
-
财政年份:2009
-
负责人:HOSOKAWA Yoshitaka
-
依托单位:
Molecular analysis of malignant lymphoma-related oncogenes and its clinical application for diagnosis and treatment.
-
批准号:15591034
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.24万
-
财政年份:2003
-
负责人:HOSOKAWA Yoshitaka
-
依托单位:
Molecular analysis of B-cell malignant lymphoma-related oncogenes and its clinical application for diagnosis and treatment.
-
批准号:13671091
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.62万
-
财政年份:2001
-
负责人:HOSOKAWA Yoshitaka
-
依托单位:
Functional analysis of cyclin D1 alternative transcript b
-
批准号:10670980
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.37万
-
财政年份:1998
-
负责人:HOSOKAWA Yoshitaka
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
-
批准号:31970691
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:张胜萍
-
依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
-
批准号:31900527
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:孙磊
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
姜黄素与TRAIL的协同抗肿瘤机制研究
-
批准号:31101223
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2011
-
负责人:曹林
-
依托单位:
转凝蛋白通过线粒体凋亡途径致足细胞凋亡的机制研究
-
批准号:81100502
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2011
-
负责人:管娜
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位: